Skip to main navigation Skip to search Skip to main content

A 26 Week, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase 3 Trial Evaluating the Safety and Efficacy of Dapagliflozin and Saxagliptin in Pediatric Patients with Type 2 Diabetes Mellitus between 10 and 18 ye

Project: Research

Project Details

StatusActive
Effective start/end date07/26/21 → 12/31/26

Funding

  • Pharmaceutical Research Associates Incorporated: $37,653.48